Literature DB >> 12726988

Inactivation of mprF affects vancomycin susceptibility in Staphylococcus aureus.

Alexey Ruzin1, Anatoly Severin, Soraya L Moghazeh, Jerome Etienne, Patricia A Bradford, Steven J Projan, David M Shlaes.   

Abstract

A chemically generated mutant of Staphylococcus aureus RN4220, GC6668, was isolated that had a fourfold increase in resistance to vancomycin. This phenotype reverted back to susceptibility by insertional mutagenesis with Tn917. In a selected set of revertants, Tn917 insertion was mapped to a unique chromosomal region upstream of mprF, a recently described gene that determines staphylococcal resistance to several host defense peptides. The genetic linkage between the vancomycin susceptibility and Tn917 insertion was then confirmed by transduction backcrosses into both GC6668 and GISA isolates, MER-S12 and HT2002 0127. Northern blot analysis, insertional inactivation and complementation experiments showed that mprF mediates vancomycin susceptibility in S. aureus. The inactivation of mprF by Tn917 insertion in HT2002 0127 caused a significant increase in the binding of vancomycin to the cell membranes. This observation serves as a likely mechanism of the increased vancomycin susceptibility associated with mprF inactivation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12726988     DOI: 10.1016/s0304-4165(03)00028-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  29 in total

Review 1.  Roles of tRNA in cell wall biosynthesis.

Authors:  Kiley Dare; Michael Ibba
Journal:  Wiley Interdiscip Rev RNA       Date:  2012-01-19       Impact factor: 9.957

2.  Regulation of mprF by antisense RNA restores daptomycin susceptibility to daptomycin-resistant isolates of Staphylococcus aureus.

Authors:  Aileen Rubio; Mary Conrad; Robert J Haselbeck; Kedar G C; Vickie Brown-Driver; John Finn; Jared A Silverman
Journal:  Antimicrob Agents Chemother       Date:  2010-10-25       Impact factor: 5.191

3.  The msaABCR operon regulates resistance in vancomycin-intermediate Staphylococcus aureus strains.

Authors:  Dhritiman Samanta; Mohamed O Elasri
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

4.  Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus.

Authors:  Lisa Friedman; Jeff D Alder; Jared A Silverman
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

Review 5.  Aminoacyl-tRNAs, the bacterial cell envelope, and antibiotics.

Authors:  Uttam L RajBhandary; Dieter Söll
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-02       Impact factor: 11.205

Review 6.  Bacterial resistance mechanisms against host defense peptides.

Authors:  Tomaz Koprivnjak; Andreas Peschel
Journal:  Cell Mol Life Sci       Date:  2011-05-11       Impact factor: 9.261

7.  In vivo survival of teicoplanin-resistant Staphylococcus aureus and fitness cost of teicoplanin resistance.

Authors:  N McCallum; H Karauzum; R Getzmann; M Bischoff; P Majcherczyk; B Berger-Bächi; R Landmann
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

Review 8.  Tuning the properties of the bacterial membrane with aminoacylated phosphatidylglycerol.

Authors:  Hervé Roy
Journal:  IUBMB Life       Date:  2009-10       Impact factor: 3.885

9.  Phenotypic and transcriptomic characterization of Bacillus subtilis mutants with grossly altered membrane composition.

Authors:  Letal I Salzberg; John D Helmann
Journal:  J Bacteriol       Date:  2008-09-26       Impact factor: 3.490

10.  Mutated response regulator graR is responsible for phenotypic conversion of Staphylococcus aureus from heterogeneous vancomycin-intermediate resistance to vancomycin-intermediate resistance.

Authors:  Hui-min Neoh; Longzhu Cui; Harumi Yuzawa; Fumihiko Takeuchi; Miki Matsuo; Keiichi Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2007-10-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.